Esparza-Guerra LT - Search Results

1

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.

Trent JC, Valero V, Booser DJ, Esparza-Guerra LT, Ibrahim N, Rahman Z, Vernillet L, Patel S, David CL, Murray JL, Cristofanilli M, Hortobagyi GN. Trent JC, et al. Among authors: esparza guerra lt. Clin Cancer Res. 2003 Jul;9(7):2426-34. Clin Cancer Res. 2003. PMID: 12855614 Clinical Trial.

2

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.

Booser DJ, Esteva FJ, Rivera E, Valero V, Esparza-Guerra L, Priebe W, Hortobagyi GN. Booser DJ, et al. Cancer Chemother Pharmacol. 2002 Jul;50(1):6-8. doi: 10.1007/s00280-002-0464-0. Epub 2002 May 21. Cancer Chemother Pharmacol. 2002. PMID: 12111105 Clinical Trial.

3

Phase I trial of dose-dense docetaxel and doxorubicin with or without sargramostim in patients with metastatic breast cancer.

Montero A, Booser D, Esparza-Guerra L, Murray J, Rosales M, Hortobagyi G, Valero V. Montero A, et al. Drugs R D. 2005;6(5):299-305. doi: 10.2165/00126839-200506050-00006. Drugs R D. 2005. PMID: 16128600 Clinical Trial. No abstract available.

4

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases.

Eckmann K, Michaud LB, Rivera E, Madden TL, Esparza-Guerra L, Kawedia J, Booser DJ, Green MC, Hortobagyi GN, Valero V. Eckmann K, et al. J Oncol Pharm Pract. 2014 Apr;20(2):120-9. doi: 10.1177/1078155213480536. Epub 2013 May 14. J Oncol Pharm Pract. 2014. PMID: 23676510

5

Phase II study of ifosfamide and mesna in patients with metastatic breast cancer.

Walters RS, Holmes FA, Valero V, Esparza-Guerra L, Hortobagyi GN. Walters RS, et al. Am J Clin Oncol. 1998 Aug;21(4):413-5. doi: 10.1097/00000421-199808000-00020. Am J Clin Oncol. 1998. PMID: 9708645 Clinical Trial.

6

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.

Valero V, Jones SE, Von Hoff DD, Booser DJ, Mennel RG, Ravdin PM, Holmes FA, Rahman Z, Schottstaedt MW, Erban JK, Esparza-Guerra L, Earhart RH, Hortobagyi GN, Burris HA 3rd. Valero V, et al. J Clin Oncol. 1998 Oct;16(10):3362-8. doi: 10.1200/JCO.1998.16.10.3362. J Clin Oncol. 1998. PMID: 9779713 Clinical Trial.

7

A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.

Theriault RL, Walters RS, Holmes FA, Esparza-Guerra L, Kowal C, Hortobagyi GN. Theriault RL, et al. Cancer Chemother Pharmacol. 1996;38(3):289-91. doi: 10.1007/s002800050484. Cancer Chemother Pharmacol. 1996. PMID: 8646805 Clinical Trial.

8

Chemotherapy-induced neutropenia and fever in patients with metastatic breast carcinoma receiving salvage chemotherapy.

Rahman Z, Esparza-Guerra L, Yap HY, Fraschini G, Bodey G, Hortobagyi G. Rahman Z, et al. Cancer. 1997 Mar 15;79(6):1150-7. doi: 10.1002/(sici)1097-0142(19970315)79:6<1150::aid-cncr13>3.0.co;2-z. Cancer. 1997. PMID: 9070492 Clinical Trial.

9

Phase I study of liposomal annamycin.

Booser DJ, Perez-Soler R, Cossum P, Esparza-Guerra L, Wu QP, Zou Y, Priebe W, Hortobagyi GN. Booser DJ, et al. Cancer Chemother Pharmacol. 2000;46(5):427-32. doi: 10.1007/s002800000177. Cancer Chemother Pharmacol. 2000. PMID: 11127949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters